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The mechanism by which cell-penetrating peptides and antimicrobial peptides cross plasma 
membranes is unknown, as is how cell-penetrating peptides facilitate drug delivery, mediating the 
transport of small molecules. Once non-disruptive and non-endocytotic pathways are excluded, pore 
formation is one of the proposed mechanisms, including toroidal, barrel-stave, or carpet models. 
Spontaneous pores have been observed in coarse-grained simulations and less often in molecular 
dynamics simulations. While pores are widely assumed and inferred, there is no unambiguous 
experimental evidence of the existence of pores. Some recent experimental studies contradict the 
mechanistic picture of pore formation, however, highlighting the possibility of a direct translocation 
pathway that is both non-disruptive and non-endocytotic.  
In this work, we propose a model for peptide (linear and dendritic) translocation which does not 
require the presence of pores and which potentially accords with such experiments. We suggest that 
a charged peptide, as it experiences an increasingly hydrophobic environment within the membrane 
surface, can utilize a proton chain transfer mechanism to shed its protons to counter ions or 
potentially phospholipid head groups in the membrane skin region, thereby becoming compatible 
with the hydrophobic interior of the membrane. This increases the likelihood to move into the 
highly hydrophobic core of the membrane and ultimately reach the opposite leaflet to re-acquire 
protons again, suggesting a potential “chameleon” mechanism for non-disruptive and non-
endocytotic membrane translocation. Our molecular dynamics simulations reveal stability of 
peptide bridges joining two membrane leaflets and demonstrate that this can facilitate cross-




Antibiotic-resistant bacteria constitute a significant public health problem1,2. Antimicrobial peptides 
(AMPs) – a class of small (≤50 residues), cationic or amphiphilic compounds – are amongst the 
most promising solutions currently known3. Cell-penetrating peptides (CPPs) are a similar class of 
peptides, important for their binding – usually via covalent conjugation through a disulfide bridge 
or by means of non-covalent interactions4 – and delivery of drugs into cells for therapeutic 
applications5–7. Both CPPs and AMPs interact strongly with the membrane surface, penetrating or 
altering its permeability via a mechanism which is not well understood8,9, even after a plethora of 
experimental and simulation studies.  
Atomistic molecular dynamics (MD) can be applied to investigate certain aspects of the uptake 
mechanisms. Despite its limitations in terms of accessible spatial and temporal scales, MD has the 
potential to provide unique insights. Several studies have converged, via observations or 
deductions, to infer the formation or existence of pores in the membrane10–14. Pores have been 
observed in coarse-grained simulations15,16, and in molecular dynamics17,18. A spontaneous 
translocation of a TAT peptide was observed in one MD study19 and explained in terms of pore 
formation. However, subsequently this result was found to have originated from incorrect use of 
electrostatic interactions14. When a phosphatidylcholine (POPC) membrane is exposed to a CPP 
such as maculatin 1.1, dye leakage was observed after ∼10 minutes. This result led the authors of 
the study to infer a physical mechanism based on membrane disruption or pore formation20. 
Binding energies of pore formation with alamethicin and melittin showed preference for 
cylindrical 21 and toroidal22 pores, in accord with molecular dynamics results23. 
In contrast to the above picture, some experiments do not support the presence of pores. 
Considering that cationic peptides should interact more strongly with negatively charged 
compounds, one would have expected pore formations with a CPP oligoarginine peptide 
interacting with negatively charged lipids. Interestingly, a leakage was observed, but not with an 
ion-conductive structure24, which would have been expected in presence of holes or channels. 
Trans-activating transcriptional (TAT) peptide penetration has been observed in the absence of 
endocytosis, with the additional discovery that added fluorophores were not taken together with 
the TAT peptide – implying the unlikelihood of formation of nonselective pores25. This result 
suggested the possibility of a hitherto unknown direct translocation mechanism7,24–26. Effects on 
lipid bilayers of the TAT peptide derived from the HIV-1 virus TAT protein were investigated with 
low-angle X-ray scattering and MD, indicating that the TAT peptide binds to the neutral 
dioleoylphosphocholine (DOPC) and furthermore its positively charged guanidinium components 
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of arginines get very close to the center of the bilayer27. Yet despite this no pore was observed: with 
MD a spontaneous water pore was generated only after constraining the peptides a t  5  Å away 
from the bilayer center.  A microsecond-long simulation with antimicrobial peptide CM15 
interacting with a POPC bilayer recorded significant membrane perturbations from the CM15 
peptide, but pores were not detected28. 
To shed more light on the issues, it is useful to summarize some of the physical membrane and 
peptide properties that can affect their membrane interactions. With arginine-rich penetrating 
peptides, a concentration threshold was discovered to be necessary for efficient translocation, 
suggesting a cooperative action by the peptides18. In another study an aggregate involving at least 
three peptides was found to be required for pore formation29. Peptide structure appears to be related 
to the pore species23, yielding specific peptide-pore pairing. The length and its ratio with the 
membrane thickness was shown to be more important than its helicity in the interactions within the 
membrane environment30. The membrane translocation abilities of oligo-arginines in living cells were 
found to depend on their chain length and peptide concentration, with nona- and deca-arginine 
attaining the best living cell transduction frequency6, also at lower concentrations31. Interestingly, a 
minimal number of six arginines per peptide in linear and/or dendritic arrangement was found 
necessary to enable transduction6. 
With the above observational data in mind, the question arises as to whether the pore is a reliable 
model able to explain how short charged peptides translocate and permeabilize the membranes. It 
is germane to make three points in this regard: (i) over the past 20 years a pore has never been 
unequivocally observed experimentally. Assuming their existence, the current explanation is that 
they should have a very short lifetime, outside the probe capability of advanced techniques such as 
solid state NMR32. (ii) simulations reporting spontaneous peptide translocation via pore formation 
should be taken very cautiously, since there is a dramatic discrepancy between the experimental 
observation of pores and the frequency of pores observed in simulations. (iii) There does exist, as 
noted above, some experimental evidence suggestive of a non-endocytotic, non-disruptive 
translocation mechanism that obviates the need to postulate pore formation.  
In this work we have undertaken simulations that lead us to propose a mechanism for peptide 
translocation of membranes without the presence of pores, disruptive events, or endocytotic 
processes. The model explains how a CPP acts as a small drug deliverer and accords naturally 
with two recent experimental results that are in striking contradiction with the pore formation 
model. Our main hypothesis is that the cationic peptide can be readily deprotonated when 
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interacting with the membrane just inside its surface, becoming more hydrophobic and increasing 
the likelihood to penetrate the strongly hydrophobic core of the membrane. The peptide behaves 
as an hydrophobic-hydrophilic chameleon, losing and then reacquiring protons as needed to 
minimize its free energy within the environment. Free energy, or potential of mean force (PMF), 
profiles calculated for peptide translocation through the membrane show that when the peptide is 
deprotonated the PMF barrier is much smaller than that for translocation of its charged 
counterpart. This confirms that the deprotonation makes the peptide much more compatible with 
the strongly hydrophobic membrane environment. We implemented QM calculations to reveal 
that arginine (Arg) guanidinium groups, when encountering an hydrophobic environment, can 
effectively donate a proton via a chain transfer mechanism to a water environment several 
angstroms away with a solvated counter ion. Since the stabilization of the proton by the 
counterion (Cl- in this case) is electrostatic rather than via a specific bond, the result carries the 
implication that hydrophilic phospholipid head groups could potentially also play such a 
stabilization role. 
Further, our simulations reveal that a trans-membrane bridging dendrimer formed in this way is 
not only stable, but provides a low energy pathway for trans-membrane migration of small drug 
molecules, exemplified in our study by the anticancer drug 5-Fluro-Uracil (5FU). 
Following methodology below, we present our simulation results and discuss the proposed 
“chameleon” model, with particular reference to two recent experimental studies that provide 
striking accord with its implications: one concerning TAT peptide membrane penetration and a 




Molecular dynamics simulations (MD) were performed using NAMD 2.10 33. The CHARMM all-
atom force field34 was used to parametrize the molecular compounds under investigation, i.e., the 
membrane, the peptides, and the small anti-cancer drug 5-fluorouracil (5-FU). CHARMM has 
been extensively validated and employed to study structure and dynamics of membranes35 and 
proteins36–38. We parameterized the amino acidic residues of our peptides using the input parameter 
file par-all36-prot34,39. The lipid membrane was downloaded from the web-based graphical 
interface CHARMM-GUI40 and parameterized with the CHARMM C36 force field for lipids39,41. 
The CHARMM-GUI input generator has been systematically tested in NAMD 42, and implements 
several input generators for biological applications, among which the module membrane 
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builder35,43,44, which we have used. 
To parameterize 5-FU we used the CHARMM compatible force field CHARMM General force 
field, or CGENFF45. Partial charges and parameters were downloaded from the CGENFF 
webserver 45, providing atom typing and assignments by chemical analogy46,47 for atomic charges, 
bond, dihedral and improper polymer parameters. The 5-FU molecule was built with the 3D builder 
in MAESTRO Schrodinger 2.8.013. Peptides were constructed patching the amino acids from the 
CHARMM protein library36,37 following the NAMD tutorial procedure48 for merging and patching 
the molecular compounds. Details for the 5-FU and peptide construction and validation have been 
detailed in our previous work49,50. Here we only mention that we validated the interactions between 
polymers and the small anticancer drug 5-FU49 by constructing several peptide dendrimers and 
demonstrating that the radius of gyration as a function of monomer size followed with good 
agreement a trend observed for similar sized polymeric systems51,52. This validation is further 
supported by the qualitative agreement found between our molecular dynamics results49 and the 
experimental results of the peptide dendrimer R4, R8, and R16 enhanced solubility effects for 5-
FU53. 
Peptides, 5-FU and membrane are arranged in a cubic box of size ∼ 6 x 6 x 10 nm3 using 
PACKMOL54 and solvated with the solvate VMD plugin55 using the water model TIP3P56. The Cl− 
ions are added to make the systems electro-neutral. Each system contains roughly 34000 total number 
of atoms with ∼10000 water molecules each. In the initial configuration, peptide and 5-FU are 
positioned in water, such that their minimum separation from the cubic box border and among 
themselves is no less than ∼1 nm in each direction.  We assume the water solution at pH=7, with 
neutral DOPC and charged octaarginne (linear) and R8 (dendritic), at the beginning. 
The peptides employed in the experimental study that we allude to in the discussion below are R4, 
which has C-to-N sequence Gly-Lys-(Arg)2; R8 with 8
+ and Gly-Lys-(Lys)2-(Arg)4; and R16 with 
16+ and Gly–Lys–(Lys)2–(Lys)4–(Arg)8, with masses 515 1084, and 2223 Da, respectively
49,50,53. In 
this work, we employ R8 and octaarginine, since R8 was the best performed as a transdermal 
permeability enhancer for 5-FU53. 
Fig. 1 plots a top view of the system, with the membrane phosphorous atoms colored in blue, a 
lateral view (center), and a 3D view (right) with the simulation box in blue, the peptide in its 
bridge configuration (green, discussed further below), and a few 5-FU molecules (yellow) 
immersed in water (red and white). Fig. 2(left) plots the chemical structure of a single membrane 
DOPC phospholipid and 5-FU on the right. Fig. 3(left) plot R8 and octaarginine (right). All the 
6  
pictures are visualized with VMD55. 
The peptide was first minimized and equilibrated in an aqueous solution, without the membrane. 
Then the full system was assembled, minimized and equilibrated for 50 ns in NPT conditions at T = 
298 K and pressure 1 bar, as for production runs. The van der Waals interactions are truncated at the 
cut off distance of 1.2 nm with a smooth switching function 33. All pairs of bonded atoms that match 
the 1 − 4 criteria are excluded 33. Periodic boundary conditions are used in each direction. The 
Particle Mesh Ewald57 method is used to calculate the full electrostatic interactions with a grid 
spacing of 1 Å, computed every 4 steps. The temperature is kept constant with the Langevin 
thermostat and 1 fs time 
step was used to integrate the equations of motion. The velocity-Verlet integration scheme58 is 
used to evolve the atom positions. Data analysis has been conducted with TCL scripts. 
 
   
 
Fig. 1 (Left) DOPC membrane top view visualized with VMD55. Nitrogen and phosphorous atoms 
are plotted in blue. (Center) Section view of the system, with water and the DOPC membrane. 




Fig. 2 (Left) Single DOPC phospholipid downloaded from CHARMM-GUY graphical interface40, 
with the hydrophobic fatty acid tail group and head groups colored according to the CHARMM atom 
type, carbon with cyan, phosphorus with brown, hydrogen with white, oxygen with red, and nitrogen 
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with blue. (Right) Chemical structure of 5-Fluorouracil, with fluorine colored in yellow. Pictures 










Fig. 3 (Left) Chemical structure of R8 and (Right) octaarginine. Visualization with VMD55 
embedded in VMD55 and python 
 
We model the membrane with dioleylphosphatidylcholine (DOPC), one of the most typical cell 
membrane lipids with one tail composed of eighteen carbon atoms and one double-bond in the middle 
of each chain (unsaturation), and with a transition temperature of –16.5 ◦C59, therefore existing in 
the fluid like liquid crystalline state (Lα
60) at room temperature. 
The surface, or outer leaflet, of mammalian cell membranes is composed of electrically neutral, 
zwitterionic phospholipids, hence DOPC is the appropriate model membrane in our study61. To 
validate our implementation, we compare the DOPC area per lipid of the CHARMM model, A= 69.7 
Å2 35,39–44 with our MD measurements. The number of DOPC phospholipids is our system is ND = 104 
with 52 molecules per leaflet, with the surface area per lipid equal to the averaged area of the lateral 
dimensions (x and y) of the simulation box divided by ND/2. The time series of the area per lipid is 
plot in Fig. 4 (left), and the relative histogram on Fig.  4 (right).  The result shows that the expected 
value A= 69.7 Å2, evidenced with the vertical bar in Fig. 4 (right), is within the range of our MD 
measurement. 
In our MD results we have not observed any event, neither a 5-FU entrance inside the membrane, 
nor a peptide translocation, on time scales of the order of 1 µs. Given the slow diffusion of solutes 
in the membrane (∼108 cm2s−1)62 advanced sampling techniques in molecular simulation can be 
utilized to assess the free-energy profile across the membrane, and to examine events which cannot 














Fig. 4 (Left) DOPC surface area per lipid with time. The inset units are the same as the main graph. 
(Right) Histogram of the instantaneous area per lipid with 150 bins, with the vertical bar reporting 
the value A= 69.7 Å2 suggested by the literature35,39–44 
 
Free energy calculations are made using the ABF63,64 method, with its implementation in 
NAMD33.  We averaged for 40 ns in total for each of the 15 windows of width 2 Å, to cover a 
distance of 0 – 30 Å across the reaction coordinate.  We verified that after 20 ns from the beginning the 
PMF profile does not change. Hence, our PMF profile, which is averaged over the successive 20 ns, is 
convergent. The bin count per window was larger than 105. 
The reaction coordinate employed to investigate the 5-FU permeation through the lipid bilayer is 
the distance of the permeant molecule center of mass and the bilayer center, projected onto the 
bilayer normal. The same reaction coordinate is applied when the 5-FU PMF is computed in 
presence of R8. The peptide is positioned perpendicularly to the two membrane leaflets, with 5-FU 
located at the initial configuration, in its assigned window and within 0.8−1 nm from the peptide, 
i.e., not too close to perturb the peptide bridge configuration, affecting the outcome, and not too 
far away such that 5-FU would simply abandon the peptide choosing a random direction along the 
slab. Note that the 5-FU is free to diffuse in its assigned parallel slab, that is, is free to diffuse in 
the hydrophobic environment along the x-y directions. Note also that, after the peptide has been 
dragged into its bridge or ladder configuration, it is left free, that is, in our PMF computation, the 
whole system is free and nowhere are applied external constraining forces.  
Conscious that the parametrized MD force-field will not effectively describe the propensity for 
proton shedding by the charged peptide, we have undertaken reduced-model quantum chemical 
calculations to explore this process as described in detail below. The quantum chemical 
calculations were carried out using B3LYP/6-31G(d) in n-hexane implicit solvent, employing the 
polarizable continuum model (PCM) using the integral equation formalism variant (IEFPCM)65 as 
implemented in Gaussian66 suite of programs. The implicit hydrophobic solvent, n-hexane, was 
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First, we study the behavior of a free peptide diffusing in water and in presence of a DOPC 
membrane. Almost immediately (∼50 ns), the peptide interacts with the membrane and will not 
detach for the next ∼2 µs, suggesting very strong electrostatic interactions. We plot the distance 
between the R8 center of mass and the membrane surface center of mass in function of time in Fig. 5 
(left). The membrane surface centre of mass is computed as the average center of mass (CM) 
position of the phospholipid’s head nitrogen atoms. The plot indicates that the R8’s CM remains 
prevalently under the external surface, but does not enter the hydrophobic core on the time scale 
examined.  
Following the strategy outlined in the Introduction and Methods, we deprotonate R8 after 1.2 µs 
passing from Q=+8 e to Q=0, and then continue the simulation for a  further ∼800ns. The R8-
membrane relative position is not affected, for R8 remains close to the bilayer surface without 
penetrating further. We use this average position, attained without applying any external constraint 
force, as the starting point for the calculation of the free energy profile for translocation. It is 
important to note that this procedure is different from the standard method to compute 
translocation free energies, where it is computed starting with the peptide located in water. 
However, since the proposed model involves a possible change of charge state once the peptide 
has diffused inside the leaflet this is a practical common starting point to consider the comparative 
free energy profiles with and without deprotonation. In Fig. 5 (right) the reaction coordinate 
crosses the membrane perpendicularly and the distance corresponding to 20 Å in the picture is the 
CM position attained by the peptide after 1.2 µs simulation time (the final part of the red profile in 
Fig. 5(left)). The zero point on the x-axis corresponds to the center of the membrane. The PMF 
result in Fig. 5 (right), obtained with the ABF method63,64, indicates 52 kcal/mol for R8 with 
Q= +8e (e is the elementary electric charge, 1.6 × 10−19 Coulomb). Computing the PMF starting 
from the same position but after deprotonating R8, the barrier is reduced a factor of ~5, indicating 
that the deprotonation strongly increases the peptide-membrane hydrophobic core affinity. In turn, 
the likelihood for the peptide to reach the opposite leaflet is dramatically increased, implying that the 
non-disruptive translocation may be a much more probable event than hitherto believed. It is 
interesting to note that the translocation free energy of a single arginine amino acid through a 
DPPC bilayer was found to be 13.3 kcal/mol67 (with the CHARMM forcefield34), very similar to 
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the free energy for the whole deprotonated R8, which is made from eight amino acids, as shown in 
Fig.5(left) of ∼15 kcal/mol. 
The energetic cost to transfer positively charged Arg from water to the interior of a membrane 
suggests that this process should be highly unfavourable, in striking contrast with the experimental 
evidence that CPPs cross the membrane quite easily on a timescale of minutes68. Our model 
reconciles a non-disruptive penetration mechanism with the apparently modest translocation 
energy barrier inferred from experiment, suggesting that once the peptide is deprotonated the 
hydrophobic barrier is much lower than previously thought.  
 
 
Fig. 5 (Left) Distance as a function of time between the center of mass of the peptide and the 
center of mass of the external surface of the membrane, computed averaging over the nitrogen 
atoms of its phospholipid headgroups. When R8 is protonated the time profile is plot with red, when 
it is deprotonated (Q=0) with green. (Right) PMF of the peptide translocation through the 
membrane. The black profile corresponds to the PMF of R8 with charge Q= +8 e, and the red 
profile plots the PMF of the deprotonated peptide. In both PMFs, the initial peptide position is the 
one attained at 1.2 µs of the picture on the left. 
 
We must point out that our deprotonation scheme is in contrast with most literature which states 
that Arg keeps its positive charges within the hydrophobic environment of the membrane69–73, 
with relatively few cases arguing for a possibility of both the protonated and neutral state74. The 
problem is still under debate9 and involves considerable complexity, given the influence that water 
defects and membrane deformation can have on the energetics of partitioning69,74. The pKa of Arg 
is predicted to remain relatively constant at least until it is already close to the hydrophobic centre 
of the membrane69,75, apparently belying the likelihood that the peptide could shed its protons as it 
starts to penetrate the hydrophobic region. This begs the mechanistic question as to how such 
proton loss might actually occur.  
In considering the mechanism for proton loss by the peptide, we start with a simple question: 
would the proton be more stable (a) on Arg in the hydrophobic lipid environment or (b) out in the 
11  
exterior skin region where there is water and counter-ions? Clearly, the latter environment should 
more readily stabilize and solvate the excess proton. However, once the peptide starts to penetrate 
the membrane interior there will be perhaps several ansgtroms separation distance out to the 
exterior skin region, so by what mechanism could a proton traverse the distance back to the more 
stable environment? Noting that the water concentration decreases steadily but does not become 
negligible until well into the membrane interior (see Fig. 9, left panel), we suggest it is entirely 
possible that water molecules can form a proton wire linking the two states. In this way, proton 
chain transfer – a phenomenon well known in other biological contexts such as the Green 
Fluorescent Protein photocycle76  - presents itself as a likely mechanism by which the peptide can 
effectively release its excess protons back out to the membrane skin region. 
To explore this proposed mechanism in more detail, we have undertaken quantum chemical (QM) 
calculations on a representative model shown schematically in Fig. 6 below. Implicit solvent 
models implemented within the QM calculation allow the model to mimic an hydrophobic 
environment. In the current context, we wish to represent a transition from an hydrophobic 
environment further into the membrane to an hydrophilic environment in the exterior skin region. 
Since the implicit solvent model is applied to the whole system, we represent the hydrophilic 
exterior region by a water cluster, so that the interior of the cluster may reasonably approximate the 
hydrophilic environment in the exterior region. We include a Cl- counter ion within the water 
cluster to represent the fact that there are negatively charged species in the exterior skin 
environment (either counter ions or phospholipid head groups) that can electrostatically stabilize 
the hydrated proton in that region. For simplicity we use a single Arg residue in place of the 
dendrimer. With this model in mind, we postulate that the energy gradient for the overall charge 
transfer due to the change in hydrophobicity between the membrane interior and the membrane skin 
region could drive the proton chain transfer and thence provide the mechanism for deprotonation. 
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Fig. 6 Schematic of QM model 
 
Following this strategy, the upper frame of Fig. 7 shows initial state for the proton transfer with 
the excess proton on the Arg residue, optimized at the B3LYP/6-31G(d) level of theory. The lower 
frame shows the final optimized state where the proton resides in the vicinity of the Cl – counter ion 
within the water cluster. Note that this final state involves a loose electrostatic stabilization of the 
proton by the counter ion rather than a dative bond; hence, even a phospholipid head group could 
potentially play such a role. In Fig.7, we have cropped extraneous atoms in the models and 
highlighted in white the atoms directly involved in this proton-chain transfer pathway for visual 
clarity; complete figures with atomic colour scheme are provided in the supplementary information 
(Figure S1). For this model, we included three bridging water molecules between Arg and the water 
cluster to exemplify a proton wire arrangement. To facilitate the calculations, we have constrained 
the positions of the O atoms of the bridging water molecules and water cluster, as well as the 
counterion. As mentioned earlier, an implicit hydrophobic (n-hexane) solvent model was applied, 
employing the polarizable continuum model (PCM) using the integral equation formalism variant 
(IEFPCM)65 as implemented in Gaussian66 suite of programs. The calculated energies reveal that 
the final state with the excess proton in the water cluster is ~ 40 kcal more stable than the initial 







Fig. 7 Initial (upper frame) and final (lower frame) optimized QM model structures for proton 
chain transfer from protonated Arg. The white highlighted portion indicates the proton transfer 
pathway. 
 
It remains to explore the energetics of the proton chain transfer. The complexity of this system 
prohibited successful utilization of the automatic minimum energy pathway searching method as 
implemented within Gaussian. In lieu thereof, we have used a simple approach to generate a 
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coarse-grained pathway involving motions of the protons. We move protons 78, 47, 51, 5, 39, 17 
and finally 53 in a manner that approximately maintains the H-O-H bond angles for the water 
molecules (~105°) throughout the transfer and reaches the desired final structure where the proton 
resides inside the water cluster. We divided the path of each of the protons into 6 intervals, giving 6 
points along the pathway of each. We implemented three different scenarios for collective motion 
of the protons that would result in an overall proton chain transfer from the protonated Arg to the 
water cluster. The first set of movements represents a “push” mechanism where the collective 
motions start from the first proton in the chain and propagate forward along the chain like falling 
dominoes. From point to point along the pathway, these motions can be described as follows: 
1. Initial point 
2. Move 78 by 1 step and compute energy. 
3. Move 78 by a 2nd step and move 47 by 1 step and compute energy. 
4. Move 78 by a 3rd step; move 47 by a 2nd step; move 51 by 1 step and compute energy.  
5. Move 78 by a 4th step; move 47 by a 3rd step; move 51 by a 2nd step and move 5 by 1 step 
and compute energy; and so on until the final state is reached.  
The second set of movements represents a “pull” mechanism wherein the last proton in the chain 
moves first, initiating a cascade of (forward) movements that propagates back along the chain (i.e., 
the first proton in the chain is the last to start moving) until all protons have reached their final 
positions. The final set of movements is fully “synchronous”, wherein each proton in the chain 
moves one increment at the same time as all the others. The specific H-bond lengths for these three 
different propagation scenarios are shown explicitly in Tables S1-S3 of the Supplementary 
Information together with the computed energies, which are plotted to yield the three corresponding 
potential energy profiles in Fig.8. Interestingly, we find that the “push” and “pull” mechanisms 
have similar energetic barriers and are much lower than that computed for the synchronous 
mechanism. Clearly, these pathways are far from optimized and we expect that a fully optimized 
pathway would have a significantly lower barrier.  In any event, with barriers for the unoptimized 
push and pull mechanisms less than 30 kcal, the proton chain transfer pathway seems quite feasible. 
It goes also without saying that a plethora of such proton wire pathways would be available to the 





Fig. 8 Potential energy profile obtained from single-point calculations corresponding to all the  
mechanisms described in the text. 
 
It will be apparent that the uncharged PMF profile in Fig.5 (red line, right frame) is based on an 
idealized model, whereby the dendrimer loses all its protons just after penetrating inside the 
membrane skin and then migrates into the lipid interior in an uncharged state. The implication of 
the quantum chemical model we have studied here is that the protons may be shed over a relatively 
short distance (i.e., a few Angstroms) as (i) the water concentration drops and (ii) the environment 
becomes more hydrophobic, creating the thermodynamic driver for the proton chain transfers to 
occur. Indeed, it may not even be necessary for all protons to be shed in order for the membrane 
penetration to become feasible. If one envisages all protons being shed progressively as the peptide 
penetrates into the membrane, then qualitatively the peptide PMF profile would start out along the 
fully-charged black line (right frame of Fig.5) and then progressively track across onto the 
uncharged red line as the protons are shed. We emphasize also that it is the proton chain-transfer 
mechanism – bridging the initial and final states of Fig.7 and enabling charge transfer over several 
Angstroms - that allows the energy difference between the two states to become an effective 
thermodynamic driver for the shedding of protons by the peptide. As noted above, earlier work69,75 
involving pKa calculations has shown that there is no obvious driver for proton shedding if one 
only considers local transfer of a proton. 
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It is instructive to compare our model with two experiments in order to tease out some of its 
implications. The first experiment employed neutron lamellar diffraction to investigate the 
interaction between a neutral DOPC membrane and TAT peptides7.  A deeper insertion of TAT was 
observed in the hydrophobic core at depth 6 Å from the center of the bilayer close to the double 
bond of fatty acyl chain7, leading the authors to suggest that TAT translocation may not depend on 
the electrostatic interactions between the ionic peptide and membrane groups interactions. Our 
model provides an easy answer here: that they are not important because the positive groups on the 
peptide lose their protons upon entry into the membrane, becoming more hydrophobic. Fig.  9(left)  
plots the mass density profile of the membrane and dendrimer atomic species. The profile is averaged 
over the whole simulation time in Fig. 5(left), including when R8 is deprotonated. Note that the 
dendrimer profile resembles a gaussian profile, analogous to that which has been found with a 
neutron diffraction experiment of the internalization of TAT peptide in DOPC phospholipid 
membrane77. Non-selective pore models, as already mentioned in the Introduction, should predict a 
roughly flat peptide mass density profile, that is, uniform across the membrane section. Our model, 
hence, provides a sensible explanation of the aforementioned experimental result7, suggesting that 
pores not only are unnecessary, but may in some cases be in contradiction with the experiment. Note 
also that in close proximity to the membrane phosphorous atoms water may be present at a density 
inferior to 1 kg/m3, likely enough to donate a proton back to the peptide when it reaches the 
opposite leaflet, reconstituting its initial Q= +8e state in water solution. Fig. 9(center) plots the 
configuration corresponding to the spontaneous location that R8 reaches after ∼ 1 µs.  
  
 
Fig. 9 (Left) Density profile of membrane, water, and the R8 dendrimer averaged over the 
simulation period of Fig.5(left); (Middle) MD snapshot at 1 µs from the simulation in Fig.5(left). 
In blue the nitrogen atoms of the DOPC membrane. (Right) MD snapshot of a membrane 
bridging structure (discussed further below). 
 
17  
Within this framework, we analyze now the second experiment related to the difficulty for 
hydrophilic drugs to partition inside membranes78, and to the necessity of chemical enhancers53. 
We examine whether our model can provide insight into apparent CPP behaviour as transdermal 
permeation enhancers, helping small drugs penetrating the skin barrier and reach the target site79. 
Without peptides the drug diffusion is driven by the gradient between the higher drug 
concentration and the target. This is a slow process and skin penetration enhancement techniques 
focus on increasing the drug flux via the transdermal route53,79. 
The experiment examined enhancement of 5-FU permeation by three different types of arginine 
terminated cationic peptide dendrimers 53, with charges 4+, 8+, and 16+, named R4, R8, and R16. It 
employed human skin excised epidermis mounted on a support, so as to separate the donor and the 
receptor compartments53, with the donor chamber containing a saturated 5-FU drug solution with 
varying concentration of peptides. Of the three dendrimers tested, R8 bearing 8+ showed the highest 
5FU flux, or cumulative amount of drug permeated, and the greatest amount of 5FU retained in 
human skin53. Without the presence of chemical penetration enhancers, it was shown that topical 
applications of 5FU show poor permeability80. Outstanding questions from the findings of the study 
include why the dendrimers enhance permeability; and why R8 is better than R4 and R16? Non-
selective pores, when large enough, predict an equally likely passage of R4, R8, and R16, and when 
not large enough should favour R4 over R8, and R8 over R16. The experimental outcome shows 
that the highest flux is attained with R8, and, interestingly, even slightly better with octaarginine, 
which possesses an identical charge and very similar size, albeit with a linear architecture. Hence, 
the experiment cannot be explained with one of the pore models.  As outlined in the introduction, 
we will argue here, via MD results, that one consequence of our proposed deprotonation scheme leads 
to a natural explanation of the 5-FU transdermal delivery experiment, whereas it is not clear that  
current pore models are compatible with the experimental trend 53.  
Implementing a scheme for incremental movement of the centre of mass, coupled with 
equilibration after each movement, we dragged the peptide R8 from water to the centre of the 
membrane. When one of its two ends reaches the opposite leaflet, a bridge formation is favoured, 
i.e., the peptide connects the two leaflets. Fig. 9(right) shows the structure of the membrane after a 
peptide has been dragged inside the membrane. Note how this induced translocation or “dragging” 
procedure alters significantly the planarity of the membrane. This may be an unavoidable artifact of 
the MD procedure used to create the starting bridge structure prior to the unconstrained 
simulations. We tried to minimize this error, picking up one single atom located at the edge of one 
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of its principal axis, to reduce the surface area of contact with the membrane during the movement 
into the core, and dragging slowly. This is the reason why we computed the PMF starting from the 
position when the peptide is already inside the membrane, that is, the position as depicted in Fig. 
9(center), which is more realistic for the present case than the standard procedure since the peptide 
reaches that location spontaneously. Alternatively, the leaflet distortion observed in Fig. 9(right) 
may in fact be a consequence of the R8 peptide being slightly too short to create a bridge without 
significant membrane surface perturbation. Since the experiments53 utilized only R4, R8 and R16 
peptides, we have not yet further explored this possibility.  
After being in contact both leaflets, R8 is then left unconstrained in the simulations and we note 
that the peptide retains its perpendicular bridging conformation during the whole free energy 
calculation with no other constraining force applied to keep the peptide in place. This bridge 
stability can be ascribed to the electrostatic interactions between the side chain protonated 
guanidinium groups of the Arg with the PO4
–
 groups of the phospholipid81,82, which form strong 
hydrogen bonds. In our MD simulations, seven 5-FU molecules are present in the water solution. 
Once the peptide is brought into its bridge configuration and thereafter left unconstrained, we 
noted that on both sides of the membrane 5-FU molecules enter the membrane, diffusing close to 
the peptide, sensing the locally hydrophilic environment there. We simulated octaarginine and R8 
bridges with 5-FU in solution and – remarkably for the finite simulation times achievable – we 
were able to observe one case where a single 5-FU entered the membrane on one side, migrated 
stochastically along the peptide bridge and emerged to the opposite side after 800 ns. This 
constitutes a 5-FU non-disruptive translocation event which did not require the presence of a pore. 
In fact, it is the first such instance of peptide-mediated drug translocation without endocytosis or 
pore formation that has been captured by atomistic MD simulations. In Fig. 10 we plot four 
snapshots taken across 700 ns, from when the 5-FU molecule start interacting with the peptide, to 
the instant when 5-FU abandons the membrane from the other side, performing a stochastic cross-






Fig. 10 5-Fluorouracil (red) crossing the membrane, as reported in four selected snapshots, from the 
beginning, top left, to the last frame when 5-FU completely crosses the membrane, bottom right. The 
peptide is green, the DOPC membrane in cyan, with water surrounding the membrane. 
 
We have also simulated 5-FU in the presence of bridged peptides with a few different trial 
protonation states, for example with a peptide deprotonated only in the membrane core but not at 
the surfaces. 5-FU enters and rolls along the peptide easily. While no complete translocation events 
were observed in these cases, we observed several 5-FU penetrations up to the center of the 
membrane. We conclude that while the peptide protonation state is important (i) in facilitating 
membrane penetration and thereby potentially bridge formation; and (ii) once formed, contributing 
to stability of the bridge through electrostatic stabilization in the leaflet regions as noted above 
(effectively “anchoring” both ends of the bridge);  the passage of 5-FU is facile regardless of peptide 
protonation state. To exemplify more quantitatively how easy it is for 5-FU to penetrate the 
membrane in presence of the peptide, we computed the PMF of 5-FU translocation across the 
membrane, with the reaction coordinate set as for the peptide, and with identical setup. Fig. 11 
plots the result, comparing the PMF of 5-FU translocation without peptide (black profile) and with 














Fig. 11 (Black) PMF for 5-FU translocation across the membrane bilayer. The reaction coordinate is 
traced along the perpendicular axis of the bilayer. The distance d= 0 on the x-axis corresponds to 
the center of the membrane. (Magenta) The PMF for 5-FU translocation across the membrane in 
the presence of an unrestrained bridging peptide. The 5-FU is initially positioned in the appropriate 
window, close to the peptide at around 0.8 nm.  
 
corresponds to the distance between the 5FU center of mass and the center of the membrane, 
projected along the z-axis. The distance d= 0 corresponds to the membrane center. The PMF is 
computed with 15 windows of 2 Å, neglecting the first 800 samples and averaging around 1 − 1.5 
× 106 samples per bin. We calculated the PMF of charged octaarginine here rather than R8 
because we observed a translocation event with octaarginine only. For translocation of the 5-FU 
alone, the PMF maximum is calculated to be around 7 kcal/mol. This is similar to a free energy 
computation of 5-FU across a DMPC bilayer, which was ∼ 10 kcal/mol83. In the presence of the 
bridging peptide, however, the PMF is zero or negative, suggesting that 5-FU traverses the 
membrane without facing any resistance.  The probability to observe a translocation event in 
molecular dynamics simulations is prohibitively low, due to the limited spatial and time scales 
currently explorable with MD, µs and tens of nanometers, necessary to overcome the high energetic 
barrier posed by the membrane hydrophobic core to hydrophilic molecules. The fact that we captured 
such an event (Fig. 10) is clearly directly related to the almost complete removal of the activation 
barrier for translocation by the presence of the peptide bridge. This result is important in that it 
provides a simple explanation about how CPPs can enhance the permeation of 5-FU or indeed other 
small drug molecules through membranes. Our proposal also provides a simple explanation of the 
experimental observation that R8 provides a better enhancement of 5-FU permeability compared 
to R4 and R1653. Quite simply, the R8 length matches the membrane thickness and is better 
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optimized for bridge formation. R4 is too small to achieve a bridge; while R16 would involve 





In this work we have proposed a model for non-invasive, non-endocytotic membrane translocation 
by cell penetrating peptides based on the potential ability of CPPs, which are positively charged in 
an aqueous environment, to shed excess protons via proton chain transfer as they experience a rapid 
decrease in water concentration and concomitant increase in hydrophobicity of the environment. 
This mechanism allows the peptides to penetrate the hydrophobic interior of the membrane with 
substantially lower free energy barriers. Our proposal does not reject the possibility that charged 
peptide residues might be stabilized within the membrane76, potentially via defect structures 
encompassing water molecules or membrane distortions. It is, however, appealing for its simplicity. 
While such membrane translocation by a peptide remains a rare event that we have not observed 
spontaneously on our µs MD  timescale, the calculated PMF profiles clearly imply its feasibility. 
The calculated density profiles based on our simulations are in accord with recent neutron lamellar 
diffraction investigations of the interaction between a neutral DOPC membrane and TAT peptides7, 
which are inconsistent with pore formation mechanisms. We note that the chameleonic shedding of 
protons does offer up the question of whether such a local increase in hydrated proton density in the 
membrane leaflet region has implications for stability of the membrane structure. This question, 
however, will require substantial additional exploration as a part of further work. 
 
Our MD simulations also reveal the potential for stable bridging structures in which the peptide 
spans the membrane. This stability is observed for both charged and non-charged bridging peptide 
structures. Such structures are seen to facilitate small drug molecule transport across the membrane, 
mediated by interactions between the drug and the bridging peptide. This offers the only current 
rationalization of recent experimental results revealing size-dependence in the enhancement 
afforded by short peptides for transdermal delivery of the anticancer drug 5FU53. We have observed 
an explicit trans-membrane delivery event - mediated by a bridging octaargenine peptide - of a 5FU 
anticancer drug during a single MD simulation, the first such demonstration via MD of non-
invasive, non-endocytotic delivery of a small drug molecule. 
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The proposed chameleon model for membrane translocation by small peptides – incorporating 
reversible proton shedding mediated through proton chain transfer - offers a new area of 
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Fig. S1: The complete figures of the proton transfer pathway. Top: The initial structure, scan point 
1, Bottom: the final structure, scan point 14.  
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Table S1: Bond distances of each scanning points in the PTP curve along with their electronic 
energies at B3LYP/6-31G(d) level of theory. The yellow highlighted portion are the increments 




Table S2: Bond distances of each scanning points in the PTP curve along with their electronic 
energies at B3LYP/6-31G(d) level of theory. The yellow highlighted portion are the increments 
done for each bonds in our adopted strategy. The mechanism is PTP-PULL. 
Scan 
points 
Bond lengths (Å) Energies (a.u.) 
N74 – H78 O46 – H47 O49 – H51 O52 – H5 O4 – H39 O37 – H17 O16 – H53 
1 1.03 0.99 0.98 0.98 0.98 0.98 0.99 -2442.8437017 
2 1.18 0.99 0.98 0.98 0.98 0.98 0.99 -2442.8386497 
3 1.33 1.14 0.98 0.98 0.98 0.98 0.99 -2442.8252374 
4 1.48 1.29 1.13 0.98 0.98 0.98 0.99 -2442.8131362 
5 1.63 1.44 1.28 1.13 0.98 0.98 0.99 -2442.8137444 
6 1.73 1.59 1.43 1.28 1.13 0.98 0.99 -2442.8144453 
7 1.73 1.69 1.58 1.43 1.28 1.13 0.99 -2442.8060953 
8 1.73 1.69 1.68 1.58 1.43 1.28 1.19 -2442.7970493 
9 1.73 1.69 1.68 1.73 1.58 1.43 1.39 -2442.814036 
10 1.73 1.69 1.68 1.73 1.73 1.63 1.59 -2442.8552341 
11 1.73 1.69 1.68 1.73 1.73 1.78 1.89 -2442.8940443 
12 1.73 1.69 1.68 1.73 1.73 1.78 2.19 -2442.9062212 
Scan 
points 
Bond lengths (Å) Energies (a.u.) 
N74 – H78 O46 – H47 O49 – H51 O52 – H5 O4 – H39 O37 – H17 O16 – H53 
1 1.70 1.68 1.69 1.77 1.77 1.81 2.43 -2442.9105898 
2 1.70 1.68 1.69 1.77 1.77 1.81 2.13 -2442.9068129 
3 1.70 1.68 1.69 1.77 1.77 1.66 1.83 -2442.8811249 
4 1.70 1.68 1.69 1.77 1.62 1.51 1.53 -2442.8325058 
5 1.70 1.68 1.69 1.62 1.47 1.36 1.23 -2442.7966 
6 1.70 1.68 1.54 1.47 1.32 1.16 0.99 -2442.8000316 
7 1.70 1.53 1.39 1.32 1.17 0.98 0.99 -2442.8051053 
8 1.55 1.38 1.24 1.17 0.98 0.98 0.99 -2442.8081477 
9 1.40 1.23 1.09 0.98 0.98 0.98 0.99 -2442.8171168 
10 1.25 1.08 0.98 0.98 0.98 0.98 0.99 -2442.8326068 
11 1.15 0.99 0.98 0.98 0.98 0.98 0.99 -2442.8405025 
12 1.03 0.99 0.98 0.98 0.98 0.98 0.99 -2442.8438304 
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Table S3: Bond distances of each scanning points in the PTP curve along with their electronic 
energies at B3LYP/6-31G(d) level of theory. The yellow highlighted portion are the increments  














Bond lengths (Å) Energies (a.u.) 
N74 – H78 O46 – H47 O49 – H51 O52 – H5 O4 – H39 O37 – H17 O16 – H53 
1 1.03 0.99 0.98 0.98 0.98 0.98 0.99 -2442.8437017 
2 1.18 1.14 1.13 1.13 1.13 1.13 1.19 -2442.7924393 
3 1.33 1.29 1.28 1.28 1.28 1.28 1.39 -2442.7314821 
4 1.48 1.44 1.43 1.43 1.43 1.43 1.59 -2442.7513012 
5 1.63 1.59 1.58 1.58 1.58 1.63 1.89 -2442.8483154 
6 1.73 1.69 1.68 1.73 1.73 1.78 2.19 -2442.9062212 
